Thiolato gold(I) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties

A series of thiolate gold(I) derivatives bearing water soluble phosphanes--namely sodium triphenylphosphane monosulfonate (TPPMS), sodium triphenylphosphane trisulfonate (TPPTS), 1,3,5-triaza-7-phosphaadamantane (PTA) and 3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane (DAPTA)--is reported and the compounds studied for their luminescence properties in the solid state. Two of these derivatives, [Au(SMe(2)pyrim)(PTA)] and [Au(SBenzoxazole)(DAPTA)], are also structurally characterized by X-ray diffraction analysis. Strong antiproliferative effects are observed for most of the compounds in the human ovarian carcinoma cell lines (A2780/S) and its cisplatin-resistant variant (A2780/R), which depend on both the type of thiolate and phosphane ligands. ICP-MS studies were also performed to evaluate the influence of the gold uptake on the cytotoxic potency of the compounds.     

The Suzuki reaction in aqueous media promoted by P, N ligands

The synthesis and structure of palladium complexes of trisubstituted PTA derivatives, PTA(R3), are described. Water-soluble phosphine ligands 1,3,5-triaza-7-phosphaadmantane (PTA), tris(aminomethyl)phosphine trihydrobromide, tri(aminomethyl) phosphine, 3,7-dimethyl-1,5,7-triaza-3-phosphabicyclo[3,3,1]nonane (RO-PTA), 3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane (DAPTA), lithium 1,3,5-triaza-7-phosphaadamantane-6-carboxylate (PTA-CO?Li), 2,4,6-triphenyl-1,3,5-triaza-7-phosphatricyclo [3.3.1.1]decane, and 2,4,6-triphenyl-1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane were used as ligands for palladium catalyzed Suzuki reactions in aqueous media. RO-PTA in combination with palladium acetate or palladium chloride was the most active catalyst for Suzuki cross coupling of aryl bromides and phenylboronic acid at 80 °C in 1:1 water:acetonitrile. The activity of Pd(II) complexes of RO-PTA is comparable to PPh?(m-C?H?SO?Na) (TPPMS) and P(m-C?H?SO?Na)? (TPPTS) and less active than tri(4,6-dimethyl-3-sulfonatophenyl)phosphine trisodium salt (TXPTS). Activated, deactivated, and sterically hindered aryl bromides were examined, with yields ranging from 50% to 90% in 6 h with 5% palladium precatalyst loading. X-ray crystal structures of (RO-PTA)PdCl?, (PTA(R3))?PdCl? (R = Ph, p-tert-butylC?H?), and PTA(R3) (R = p-tert-butylC?H?) are reported.     

Antiproliferative and bactericidal activity of diiron and monoiron cyclopentadienyl carbonyl complexes comprising a vinyl-aminoalkylidene unit

A series of diiron complexes with two cyclopentadienyls, two carbonyls, and one bridging vinyl-aminoalkylidene as ligands, [ 3a – h ]CF₃SO₃ and [ 4a – d ]CF₃SO₃, was synthesized in 66–94% yields from diiron μ-aminocarbyne precursors. The subsequent reactions with pyrrolidine led to selective fragmentation to aminoalkylidene-ferracyclopentenone derivatives ( 5a – h and 6a – c ) in 30–84% yields. The compounds were characterized by elemental analysis, Fourier transform infrared and NMR spectroscopy, and by single crystal X-ray diffraction in three cases. The stability in aqueous media relevant to biological trials, the carbon monoxide release, and the catalytic activity in NADH oxidation were evaluated for selected compounds by NMR spectroscopy and gas chromatography. The in vitro antiproliferative activity of the compounds was determined towards cancer (A2780, A2780cisR) and noncancer (HEK-293) cell lines. Moreover, the antibacterial activity was tested on Gram-positive (vancomycin-resistant E. faecium and methicillin-resistant S. aureus) and Gram-negative strains (A. baumannii and P. aeruginosa).     

Diastereomerically enriched analogues of the water-soluble phosphine PTA. Synthesis of phenyl(1,3,5-triaza-7-phosphatricyclo[3.3.1.1(3,7)]dec-6-yl)methanol (PZA) and the sulfide PZA(S) and X-ray crystal structures of the oxide PZA(O) and [Cp*IrCl(2)(PZA)

A diastereomerically enriched analogue of 1,3,5-triaza-7-phosphaadamantane (PTA) was obtained by the reaction of PTA lithium salt with benzaldehyde to give the water-soluble derivative phenyl(1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]dec-6-yl)methanol (PZA, 1) as a mixture of two diastereoisomers. PZA derivatives phenyl(1,3,5-triaza-7-phospha-tricyclo[3.3.1.13,7]dec-6-yl)methanol sulfide [PZA(S), 2] and oxide [PZA(O), 3] were also synthesized. The latter was isolated in the solid state, and the X-ray crystal structure of a single diastereoisomer was obtained. Compound 1 was used as a k1-P monodentate ligand toward iridium(III) moieties, and the piano-stool complex [Cp*IrCl2(PZA)] (4) was obtained as a mixture of diastereoisomers both in solution and in the solid state.     

Efficient and selective hydration of nitriles to amides in aqueous systems with Ru(II)-phosphaurotropine catalysts

A simple and efficient synthesis of amides by selective hydration of aromatic and aliphatic nitriles is described. The catalysts are prepared in situ from easily available Ru-precursors and ligands using water as the solvent. The most active catalyst, is obtained from [RuCl₂(dmso)₄] and benzylated 1,3,5-triaza-7-phosphaadamantane. Of the 16 substrates examined, 92–99% conversions of 14 nitriles were achieved in one hour at reflux temperature.     

Synthesis and Cytotoxicity of 2‐(2′‐Pyridyl)benzimidazole Complexes of Palladium(II) and Platinum(II)

Compounds of type [MX₂(Hpben)] [M = Pd (X = Cl), Pt (X = Cl, I); Hpben = 2‐(2′‐pyridyl)benzimidazole] were prepared and characterized, and the structures of the Pt derivatives were determined by X‐ray crystallography. The crystals of [PtI₂(Hpben)] consist of discrete units in which the Pt atom is coordinated to two iodine atoms and to pyridine and imidazole N atoms in a distorted square planar arrangement. The structure of the chloro derivative is similar, except that the [PtCl₂(Hpben)] monomers are hydrogen‐bonded in zig‐zag chains. In assays of the interactions of the Pd and Pt chloro compounds with DNA, and of their in vitro cytotoxic activity against human cervical carcinoma cells (HeLa‐229), human ovarian carcinoma cells (A2780) and a cisplatin‐resistant mutant A2780 line (A2780cis), the only activity observed was modest cytotoxicity of the Pd derivative for A2780.     

Synthesis of the water soluble ligands dmPTA and dmoPTA and the complex [RuClCp(HdmoPTA)(PPh(3))](OSO(2)CF(3)) (dmPTA = N,N'-Dimethyl-1,3,5-triaza-7-phosphaadamantane, dmoPTA = 3,7-Dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane, HdmoPTA = 3,7-H-3,7-Dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane)

The new water-soluble ligand dmPTA(OSO(2)CF(3))(2) (1) (dmPTA = N,N'-dimethyl-1,3,5-triaza-7-phosphaadamantane) has been synthesized by reaction of PTA with MeOSO(2)CF(3) in acetone (PTA = 1,3,5-triaza-7-phosphatricycle[3.3.1.1(3,7)]decane). The reaction of 1 with KOH gave rise to the new water-soluble ligand dmoPTA (3) (dmoPTA = 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane) by elimination of the -CH(2)- group located between both NCH(3) units. Compound dmPTA(BF(4))(2) (2) and complex [RuClCp(HdmoPTA)(PPh(3))](OSO(2)CF(3)) (4) have also been synthesized, while compounds HdmoPTA(BF(4)) (3a) and [RuClCp(dmPTA)(PPh(3))](OSO(2)CF(3)) (5) were characterized but not isolated. The new ligands and the complex have been fully characterized by NMR, IR, elemental analysis, and X-ray crystal structure determination (ligand 1 and complex 4). The synthetic processes for 3 and 4 were studied.     

Water-Soluble O-, S- and Se-Functionalized Cyclic Acetyl-triaza-phosphines. Synthesis,Characterization and Application in Catalytic Azide-alkyne Cycloaddition

The 3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane (DAPTA) derivatives, viz. the already reported 3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane 5-oxide (DAPTA=O, 1), the novel 3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane-5-sulfide (DAPTA=S, 2), and 3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane-5-selenide (DAPTA=Se, 3), have been synthesized under mild conditions. They are soluble in water and most common organic solvents and have been characterized using ¹H and ³¹P NMR spectroscopy and, for 2 and 3, also by single crystal X-ray diffraction. The effect of O, S, or Se at the phosphorus atom on the structural features of the compounds has been investigated, also through the analyses of Hirshfeld surfaces. The presence of 1–3 enhances the activity of copper for the catalytic azide-alkyne cycloaddition reaction in an aqueous medium. The combination of cheaply available copper (II) acetate and compound 1 has been used as a catalyst for the one-pot and 1,4-regioselective procedure to obtain 1,2,3-triazoles with high yields and according to ‘click rules’.     

Tricarbonylrhenium(I) complexes with the N,6-dimethylpyridine-2-carbothioamide ligand: combined experimental and calculation studies

Abstract

A new series of tricarbonyl complexes of rhenium(I) in the “2 + 1” system with the bidentate ligand N,6-dimethylpyridine-2-carbothioamide ((CH₃)NC₅H₄-CS-NH-CH₃, MeLH(Me)_NS) and a monodentate ligand (halides Cl, Br, or I, and the pseudohalide NCS anion) was synthesized. The use of mixed ligands led to the formation of neutral tricarbonylrhenium(I) complexes [Re(CO)₃(MeLH(Me)_NS)X] (X = Cl, Br, I, NCS) (1–4). Single-crystal X-ray diffraction was used to determine the crystal structures of all four compounds and those results were compared with molecular structures obtained from DFT calculations using the PBE0/def2-TZVPD approach. The complexes were also characterized by spectroscopic (FT-IR, NMR, and UV–vis) and analytical (HPLC, TGA, EA, ESI-MS) techniques. IR and UV–vis spectra were also calculated by DFT and TD-DFT methods. The cytotoxicity of these complexes was estimated using human ovarian cancer cell lines (A2780 and A2780cis), cervical cancer cells (HeLa), and non-cancerous human embryonic kidney cells (Hek-293). The toxicity of most complexes was moderate or low toward cancer cell lines (IC₅₀ = 46–231 μM) and similar against non-cancerous cells (IC₅₀ = 41-121 μM). Only the complex with chlorido ligand remarkably inhibited growth of ovarian cancer cells (IC₅₀ = 3 and 12 μM for A2780 and A2780cis, respectively). The cytotoxicity of 1 was higher than that of cisplatin.     

杂环光化学Ⅴ.烯类与1,3-二甲基-6-氮杂胸腺嘧啶的光环合加成反应

1974年Sweeton等人首先报道了这一反应^[1]。1981年樊美公等报道了1,3-二甲基-6-氮杂胸腺嘧啶(A)与庚烯-1的反应^[2],1986年又相继报道了含有极性基团的烯类与A的反应。本文通过这类反应合成了新化合物:1,2,4-三氮杂-2,4,6,7-四甲基-3,5-二氧-8-正丁基双环[4,2,0]辛烷(Ⅰ)和1,2,4-三氮杂-2,4,6-三甲基-3,5-二氧叁环[6,4,0,0^7,12]十二烷甲基衍生物(Ⅱ)。     

Some reactions of 1,3,5-Triaza-7-phosphaadamantane and its 7-Oxide

The synthesis of 1,3,5,7-triazaphosphocine and 1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane derivatives via nitration, nitrosation and acetylation of 1,3,5-triaza-7-phosphaadamantane and its 7-oxide is reported. A comparison of the reactions of the triazaphosphaadamantane with the analogous reactions of hexamine is made.     

Synthesis of 2-(2,3,4-trimethoxyphenyl)-1-(substituted-phenyl)acrylonitriles: in vitro anticancer activity against MCF-7, PC-3 and A2780 cancer cell lines

A series of 2-(2,3,4-trimethoxyphenyl)-1-(substituted-phenyl)acrylonitrile (2–9) were designed and synthesized to develop new cancer drugs. The structures of synthesized compounds 2–9 were described by using melting point, mass (MALDI-TOF-MS), FT-IR, elemental analysis, ¹H, ¹³C, ¹³C-APT and 2D NMR spectroscopy. The in vitro anticancer activities of 2–9 against human breast cancer (MCF-7), human prostate cancer (PC-3) and human ovarian cancer cells (A2780) were investigated by [3-(4,5-dimethylthiazol)-2-yl]-2,5-diphenyl-2H-tetrazolium bromide] (MTT) assay method. Additionally, the LogIC₅₀ values of these compounds on A2780, MCF-7 and PC-3 cell lines were calculated by using inhibition % values by the GraphPad Prism 6 program on a computer. The results indicated that these compounds have high anticancer activity against MCF-7, PC-3 and A2780 cell lines (especially A2780 cell lines, p < 0.05).     

Bis-conjugation of Bioactive Molecules to Cisplatin-like Complexes through (2,2′-Bipyridine)-4,4′-Dicarboxylic Acid with Optimal Cytotoxicity Profile Provided by the Combination Ethacrynic Acid/Flurbiprofen

A facile route to Pt^II complexes doubly functionalized with bioactive molecules through a bipyridine-type ligand is described. Initially, ligands L ^EE (containing two ethacrynic acid units), L ^EF (ethacrynic acid+flurbiprofen) and L ^EB (ethacrynic acid+biotin) were obtained in moderate to good yields from 2,2′-bipyridine-4,4′-dicarboxylic acid. Subsequent reaction of the ligands with [PtCl₂(DMSO)₂] afforded complexes [PtCl₂( L ^EE )] ( 2 ), [PtCl₂( L ^EF )] ( 3 ) and [PtCl₂( L ^EB )] ( 4 ) in high yields. All compounds were fully characterized by analytical and spectroscopic methods. Complexes 2 – 4 are highly stable in water/DMSO solution at 37 °C after 72 h, whereas progressive release of the bioactive fragments was detected in a cell culture medium. The compounds were assessed for their in vitro antiproliferative activity towards tumorigenic A2780, A2780cisR and Y79 cells and non-tumourigenic HEK293 cells. In particular, the combination of ethacrynic acid and flurbiprofen in 3 overcomes cisplatin-based resistance and provides strong cancer cell selectivity. Enzyme inhibition assays on human GST P1 and human COX-2 and cross-experiments with complex 1 , analogous to 2 – 4 but lacking bio-groups, revealed a clear synergy between the Pt^II frame and the bioactive organic components.     

Synthesis,characterization, antibacterial,and cytotoxic activities of organotin(IV) complexes derived from N(4)-cyclohexylthiosemicarbazone: X-ray crystal structure of [Ph2SnCl(L)]

Reaction of organotin(IV) chloride(s) with 2-benzoylpyridine-N(4)-cyclohexylthiosemicarbazone, [HL] (1) yielded [MeSnCl₂(L)] (2), [BuSnCl₂(L)] (3), [Me₂SnCl(L)] (4), and [Ph₂SnCl(L)] (5). The ligand (1) and its organotin(IV) complexes have been characterized by CHN analyses, molar conductivity, UV-Vis, FT-IR, ¹H, ¹³C, and ¹¹⁹Sn NMR spectral studies. The molecular structure of 5 was also determined by X-ray diffraction. There are two independent molecules in the asymmetric unit and the central tin(IV) atom is six-coordinate in distorted octahedral geometry. The ligand (1) and complexes were screened for their in vitro antibacterial activities. The cytotoxic activities of 1–5 were tested against A2780 and A2780/Cp8 cancer cell lines. The compounds have better antibacterial activities than the free ligand; 2–5 are more potent cytotoxic agents than 1, while the diphenyltin(IV) 5 is more active with IC₅₀ values of 0.05 and 0.54?µmol?L^?1 against A2780 and A2780/Cp8 cell lines, respectively.     

Water-soluble 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane (dmoPTA) as a polydentate ligand: synthesis of [RuClCp(PPh3)-mu-dmoPTA-1kappaP:2kappa2N,N'-Co(acac-kappa2O,O')2].H2O

The dinuclear complex [RuClCp(PPh3)-mu-dmoPTA-1kappa P:2kappa(2)N, N'-Co(acac-kappa(2)O, O') 2].H 2O (2; dmoPTA = 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane) has been synthesized by reaction of [RuClCp(HdmoPTA)(PPh3)](OSO2CF3) (1) with Co(acac)2 in methanol (HdmoPTA = 3,7-H-3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane). Elemental analysis, IR, NMR, and single-crystal X-ray structure determination have characterized the new complex. This complex is active for the catalytic isomerization of but-1-en-3-ol in acetone better than 1.     

Cytotoxic gold compounds: synthesis, biological characterization and investigation of their inhibition properties of the zinc finger protein PARP-1

The new gold(III) complexes: [Au{2-(2'-pyridyl)imidazolate}Cl(2)] and [Au{2,6-bis(2'-benzimidazolate)pyridine}(OCOCH(3))] and the mono- and binuclear gold(I) complexes: [Au{2-(2'-pyridyl)imidazole}(PPh(3))](PF(6)), [Au(2-phenylimidazolate)(DAPTA)] (DAPTA = 3,7-diacetyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane), [(PPh(3)Au)(2)(2-R-imidazolate)](PF(6)) (R = 2-C(5)H(4)N, Ph) have been synthesized and characterized. The structure of the [(PPh(3)Au)(2){2-(2'-pyridyl)imidazolate)](PF(6)) complex was also characterized by X-ray crystallography. The antiproliferative properties of the complexes were assayed against human ovarian carcinoma cell lines, either sensitive (A2780) or resistant to cisplatin (A2780cisR), human mammary carcinoma cells (MCF7) and non-tumorigenic human kidney (HEK293) cells. Most of the studied compounds showed important cytotoxic effects. Interestingly, the compounds containing the 2-(2'-pyridyl)imidazolate ligand showed selectivity towards cancer cells with respect to the non-tumorigenic ones, with the dinuclear compound [(PPh(3)Au)(2){2-(2'-pyridyl)imidazolate)](PF(6)) being the most active. Some compounds were also screened for their inhibitory effect of the zinc-finger protein PARP-1, essential for DNA repair and relevant to the mechanisms of cancer cell resistance to cisplatin. Interaction studies of the compounds with the model protein ubiquitin were undertaken by electrospray ionization mass spectrometry (ESI MS). The results are discussed in relation to the putative mechanisms of action of the cytotoxic gold compounds.     

The Interactions of Low Oxidation State Transition Metal Clusters with DNA: Potential Applications in Cancer Therapy

A series of ruthenium and platinum clusters have been examined for DNA binding activity in methanol-water and water solutions. The clusters [H₄Ru₄(C₆H₆)₄]²⁺and Ru₃(CO)₉(PTA)₃(PTA=1,3,5-triaza-7-phosphatricyclo[3.3.1.1] decane) proved to be most effective; the former is believed to cross link DNA and the latter possibly intercalates. These clusters are highly water soluble and combined with their DNA damaging activity and size represent potential anticancer drugs.     

Synthesis,structure and cytotoxicity studies on diorganotin (R = Me,Et) complexes of N-methylpyridoxine (MePN,PN = Vitamin B6) containing different anions

The interaction of dimethyl- and diethyltin(IV) cations with methylpyridoxine iodide ([MePN]I; PN = pyridoxine) was studied in ethanol/water (80:20(v/v) containing Cl⁻, NO₃⁻ or I⁻ ions in different molar ratios. Several compounds containing the deprotonated (MePN-H) or neutral (MePN) ligand were isolated and characterized by elemental analysis, IR and NMR (¹H, ¹³C, ¹¹⁹Sn) spectroscopy and FAB mass spectrometry. The compounds [SnMe₂(MePN-H)](I₃), [SnEt₂(MePN-H)](I₃), [SnMe₂(MePN-H)(NO₃)], [SnEt₂(MePN-H)(NO₃)] and [SnMe₂(MePN)₂]I₂ were studied by X-ray diffractometry. The compounds in which the MePN-H ligand is present can be described as containing dinuclear [SnR₂(MePN-H)]₂²⁺ (R = Me, Et) units, in which two bridging chelating methylpyridoxinato ligands link two metal atoms. Interactions also exist between the metal and the I₃⁻ or NO₃⁻ anions and these interactions differ in degree and type. On the other hand, in the only example of a complex containing the MePN ligand, the mononuclear [SnMe₂(MePN)₂]²⁺ unit is present. The in vitro antitumor activity of these complexes against the HeLa, A2780 and A2780cis cell lines was determined and compared with that of the equivalent PN derivatives.     

Synthesis,structure and cytotoxicity studies on diorganotin (R = Me,Et) complexes of N-methylpyridoxine (MePN,PN = Vitamin B6) containing different anions

The interaction of dimethyl- and diethyltin(IV) cations with methylpyridoxine iodide ([MePN]I; PN = pyridoxine) was studied in ethanol/water (80:20(v/v) containing Cl^?, NO₃^? or I^? ions in different molar ratios. Several compounds containing the deprotonated (MePN-H) or neutral (MePN) ligand were isolated and characterized by elemental analysis, IR and NMR (¹H, ¹³C, ¹¹⁹Sn) spectroscopy and FAB mass spectrometry. The compounds [SnMe₂(MePN-H)](I₃), [SnEt₂(MePN-H)](I₃), [SnMe₂(MePN-H)(NO₃)], [SnEt₂(MePN-H)(NO₃)] and [SnMe₂(MePN)₂]I₂ were studied by X-ray diffractometry. The compounds in which the MePN-H ligand is present can be described as containing dinuclear [SnR₂(MePN-H)]₂²⁺ (R = Me, Et) units, in which two bridging chelating methylpyridoxinato ligands link two metal atoms. Interactions also exist between the metal and the I₃^? or NO₃^? anions and these interactions differ in degree and type. On the other hand, in the only example of a complex containing the MePN ligand, the mononuclear [SnMe₂(MePN)₂]²⁺ unit is present. The in vitro antitumor activity of these complexes against the HeLa, A2780 and A2780cis cell lines was determined and compared with that of the equivalent PN derivatives.     

Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds

Palladium and platinum complexes with HmtpO (where HmtpO=4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine, an analogue of the natural occurring nucleobase hypoxanthine) of the types [M(dmba)(PPh3)(HmtpO)]ClO4[dmba=N,C-chelating 2-(dimethylaminomethyl)phenyl; M=Pd or Pt], [Pd(N-N)(C6F5)(HmtpO)]ClO4[N-N=2,2'-bipyridine (bpy), 4,4'-dimethyl-2,2'-bipyridine (Me2bpy), or N, N, N', N'-tetramethylethylenediamine (tmeda)] and cis-[M(C6F5)2(HmtpO)2] (M=Pd or Pt) (head-to-head atropisomer in the solid state) have been obtained. Pd(II) and Pt(II) complexes with the anion of HmtpO of the types [Pd(tmeda)(C6F5)(mtpO)], [Pd(dmba)(micro-mtpO)] 2, and [NBu4]2[M(C6F5)2(micro-mtpO)]2(M=Pd or Pt) have been prepared starting from the corresponding hydroxometal complexes. Complexes containing simultaneously both the neutral HmtpO ligand and the anionic mtpO of the type [NBu4][M(C6F5)2(HmtpO)(mtpO)] (M=Pd or Pt) have been also obtained. In these mtpO-HmtpO metal complexes, for the first time, prototropic exchange is observed between the two heterocyclic ligands. The crystal structures of [Pd(dmba)(PPh 3)(HmtpO)]+, cis-[Pt(C6F5)2(HmtpO)2].acetone, [Pd(C6F5)(tmeda)(mtpO)].2H2O, [Pd(dmba)(micro-mtpO)]2, [NBu4]2[Pd(C6F5)2(micro-mtpO)]2.CH2Cl2.toluene, [NBu4]2[Pt(C6F5)2(micro-mtpO)](2).0.5(toluene), and [NBu4][Pt(C6F5)2(mtpO)(HmtpO)] have been established by X-ray diffraction. Values of IC50 were calculated for the new platinum complexes cis-[Pt(C6F5)2(HmtpO)2] and [Pt(dmba)(PPh3)(HmtpO)]ClO4 against a panel of human tumor cell lines representative of ovarian (A2780 and A2780 cisR), lung (NCI-H460), and breast cancers (T47D). At 48 h incubation time, both complexes were about 8-fold more active than cisplatin in T47D and show very low resistance factors against an A2780 cell line, which has acquired resistance to cisplatin. The DNA adduct formation of cis-[Pt(C6F5)2(HmtpO)2] and [Pt(dmba)(PPh3)(HmtpO)]ClO4 was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by these platinum complexes on plasmid DNA pB R322 were also obtained.